{
  "CitationSubset": [],
  "KeywordList": [
    [
      "Antipir\u00e9ticos",
      "Antipyretics",
      "Citocinas",
      "Cuidados intensivos",
      "Cytokines",
      "Fever",
      "Fiebre",
      "Intensive care",
      "Sepsis",
      "Temperatura",
      "Temperature"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "30084440",
  "DateCompleted": {
    "Year": "2019",
    "Month": "08",
    "Day": "06"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "08",
    "Day": "06"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "spa"
    ],
    "ELocationID": [
      "10.24875/BMHIM.M18000020"
    ],
    "Journal": {
      "ISSN": "1665-1146",
      "JournalIssue": {
        "Volume": "75",
        "Issue": "4",
        "PubDate": {
          "Year": "2018"
        }
      },
      "Title": "Boletin medico del Hospital Infantil de Mexico",
      "ISOAbbreviation": "Bol Med Hosp Infant Mex"
    },
    "ArticleTitle": "[Fiebre y terapia antipir\u00e9tica en el paciente con sepsis en la unidad de cuidados intensivos: actualizaci\u00f3n].",
    "Pagination": {
      "StartPage": "203",
      "EndPage": "215",
      "MedlinePgn": "203-215"
    },
    "Abstract": {
      "AbstractText": [
        "La fiebre es un signo frecuente en el ni\u00f1o cr\u00edticamente enfermo durante su estad\u00eda en la unidad de cuidados intensivos, y debe ser entendida como una respuesta biol\u00f3gica evolutiva, de car\u00e1cter adaptativo normal del hu\u00e9sped al estr\u00e9s fisiol\u00f3gico. Es el resultado de una compleja respuesta a est\u00edmulos pirog\u00e9nicos, resultando en la generaci\u00f3n de citocinas y prostaglandinas. Los mecanismos moleculares implicados en el inicio de la fiebre a\u00fan no est\u00e1n totalmente precisados, originando dificultades en el conocimiento de los procesos fisiopatol\u00f3gicos exactos involucrados y, por ende, necesarios para elaborar una adecuada y espec\u00edfica estrategia terap\u00e9utica. Estudios experimentales concluyen que la fiebre y la inflamaci\u00f3n son ben\u00e9ficas para el hu\u00e9sped; no obstante, la terapia antipir\u00e9tica es com\u00fanmente empleada y estudios en humanos sobre la presencia de fiebre y su tratamiento para el pron\u00f3stico del paciente cr\u00edtico con sepsis no son concluyentes. Para el m\u00e9dico intensivista es esencial disponer de informaci\u00f3n actualizada referente a la fisiolog\u00eda de la termorregulaci\u00f3n humana, el efecto de la temperatura en rango febril sobre m\u00faltiples procesos biol\u00f3gicos involucrados en la defensa del hu\u00e9sped y las intervenciones termorreguladoras en el paciente con sepsis. Fever is a very common sign to observe in critically ill children during their intensive care unit stay. This should be understood as an evolutionary biological response, of normal adaptive character, from the host to the physiological stress. It is the result of a complex response to pyrogenic stimuli, resulting in the generation of cytokines and prostaglandins. The molecular mechanisms involved in the onset of fever are not yet fully specified, thus creating difficulties in the knowledge of the exact pathophysiological processes involved and, therefore, necessary to elaborate an adequate and specific therapeutic strategy. Experimental studies conclude that fever and inflammation are beneficial to the host. However, antipyretic therapy is commonly employed and human studies on the presence of fever and its treatment for the prognosis of critically ill septic patients are inconclusive. Up-to-date information on the physiology of human thermoregulation, the effect of temperature on febrile range over multiple biological processes involved in host defense, and thermoregulatory interventions in the septic patient are essential to know by the critical care physician."
      ],
      "CopyrightInformation": "Copyright: \u00a9 2018 Secretar\u00cda de Salud."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Unidad de Paciente Cr\u00edtico Pedi\u00e1trico, Hospital Cl\u00ednico Metropolitano La Florida, Santiago, Chile."
          }
        ],
        "LastName": "Donoso",
        "ForeName": "Alejandro",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Unidad de Paciente Cr\u00edtico Pedi\u00e1trico, Hospital Cl\u00ednico Metropolitano La Florida, Santiago, Chile."
          }
        ],
        "LastName": "Arriagada",
        "ForeName": "Daniela",
        "Initials": "D"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ],
    "VernacularTitle": "Fever and antipyretic therapy in the septic patient in the intensive care unit: an update."
  },
  "MedlineJournalInfo": {
    "Country": "Mexico",
    "MedlineTA": "Bol Med Hosp Infant Mex",
    "NlmUniqueID": "0414106",
    "ISSNLinking": "0539-6115"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antipyretics"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antipyretics"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Critical Care"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Critical Illness"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Intensive Care Units"
    },
    {
      "QualifierName": [
        "drug therapy",
        "physiopathology"
      ],
      "DescriptorName": "Sepsis"
    }
  ]
}